Significance and prognostic role of human epidermal growth factor receptor 2 and RAB1A expression in gastric cancer.

about

Significance and prognostic role of human epidermal growth factor receptor 2 and RAB1A expression in gastric cancer.

Item

http://www.wikidata.org/entity/Q55123690

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Significance and prognostic ro ...... expression in gastric cancer.

@en

Significance and prognostic ro ...... expression in gastric cancer.

@nl

type

Item

label

Significance and prognostic ro ...... expression in gastric cancer.

@en

Significance and prognostic ro ...... expression in gastric cancer.

@nl

prefLabel

Significance and prognostic ro ...... expression in gastric cancer.

@en

Significance and prognostic ro ...... expression in gastric cancer.

@nl

P1476

Significance and prognostic ro ...... expression in gastric cancer.

@en

P2093

Bihong Xu

http://www.w3.org/2001/XMLSchema#string

Chunyu Huang

http://www.w3.org/2001/XMLSchema#string

Liang Li

http://www.w3.org/2001/XMLSchema#string

Xiangzhao Li

http://www.w3.org/2001/XMLSchema#string

Xianzi Yang

http://www.w3.org/2001/XMLSchema#string

Yanqing Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Rab1A is an mTORC1 activator and a colorectal oncogene

Proteomic analysis of endocytic vesicles: Rab1a regulates motility of early endocytic vesicles.

Current and emerging therapies in unresectable and recurrent gastric cancer

HER2 testing in gastric cancer: An update

Potential of overcoming resistance to HER2-targeted therapies through the PI3K/Akt/mTOR pathway

Role of Rab GTPases in membrane traffic and cell physiology

Aberrant expression of RAB1A in human tongue cancer.

Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer.

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy.

P304

5185-5192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.7992

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29552156

http://www.w3.org/2001/XMLSchema#string

P932

5840653

http://www.w3.org/2001/XMLSchema#string